Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/2000
07/27/2000WO2000043414A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions
07/27/2000WO2000043408A2 Steroid sulfatase inhibitors and methods for making and using the same
07/27/2000WO2000043407A1 Remedies
07/27/2000WO2000043404A1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases
07/27/2000WO2000043397A1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases
07/27/2000WO2000043393A1 Novel angiogenesis inhibitors
07/27/2000WO2000043392A2 Use of imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones as medicaments
07/27/2000WO2000043382A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
07/27/2000WO2000043378A1 New morpholinobenzamide salts
07/27/2000WO2000043373A2 Kinase inhibitors
07/27/2000WO2000043370A1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
07/27/2000WO2000043362A1 Phenylsulphonyl derivatives as 5-ht receptor ligands
07/27/2000WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000WO2000043038A1 Methods and devices for delivery of agents to breast milk ducts
07/27/2000WO2000043036A2 Lipoprotein complexes and compositions containing them
07/27/2000WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response
07/27/2000WO2000043023A1 Pharmaceutical composition with adhesion molecule expression regulating activity
07/27/2000WO2000043018A1 Medicinal compositions
07/27/2000WO2000043008A1 Anti-androgens and methods for treating disease
07/27/2000WO2000043001A1 Anti-inflammatory agents
07/27/2000WO2000043000A1 Proteasome inhibitors
07/27/2000WO2000042852A1 Compounds and methods
07/27/2000WO2000042841A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
07/27/2000WO2000028980A3 Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain
07/27/2000WO2000028010A3 The genetic determination of genes and its use for the prophylaxis and therapy of diseases
07/27/2000WO2000027998A3 Method and compositions for improving allogeneic hematopoietic cell transplantation
07/27/2000WO2000027832A3 Thiazole derivatives as ppar gamma ligands
07/27/2000WO2000025723A3 Methods and compositions for the prevention of tolerance to medications
07/27/2000WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation
07/27/2000WO2000023057A3 Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition
07/27/2000WO2000018915A3 Membrane-associated organizational proteins
07/27/2000WO2000012683A9 Stem cells bearing an fgf receptor on the cell surface
07/27/2000WO2000008202A9 3-methylidenyl-2-indolinone modulators of protein kinase
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses
07/27/2000WO1999055322A9 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
07/27/2000WO1999036431A9 Compounds with growth hormone releasing properties
07/27/2000DE10003356A1 Novel ribozymes targeted against the catalytic subunit of the human telomerase enzyme reverse transcriptase are useful for treating tumors
07/27/2000CA2361272A1 33 human secreted proteins
07/27/2000CA2361168A1 Steroid sulfatase inhibitors and methods for making and using the same
07/27/2000CA2361123A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
07/27/2000CA2361122A1 Methods and devices for delivery of agents to breast milk ducts
07/27/2000CA2361059A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
07/27/2000CA2360787A1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases
07/27/2000CA2360065A1 Lipoprotein complexes and compositions containing them
07/27/2000CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response
07/27/2000CA2359983A1 Phenylsulphonyl derivatives as 5-ht receptor ligands
07/27/2000CA2359680A1 Kinase inhibitors
07/27/2000CA2359561A1 Proteasome inhibitors
07/27/2000CA2359145A1 Exocytosis pathway proteins and methods of use
07/27/2000CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359105A1 New morpholinobenzamide salts
07/27/2000CA2359096A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions
07/27/2000CA2358971A1 Identifying, monitoring, and treating women for breast precancer or cancer
07/27/2000CA2358899A1 Polypeptide
07/27/2000CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000CA2356642A1 Improved phytases
07/27/2000CA2356349A1 Novel angiogenesis inhibitors
07/27/2000CA2353903A1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases
07/26/2000EP1022331A2 Transdifferentiation of transfected epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells
07/26/2000EP1022330A2 Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells
07/26/2000EP1022029A1 Nootropic agent
07/26/2000EP1022026A2 Pharmaceutical compositions for treating nitrate-induced tolerance
07/26/2000EP1022023A1 Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora
07/26/2000EP1021564A1 Process for detecting, extracting or removing human or mammalian cells with a disturbed cellular cycle regulation or unlimited proliferation or tumour-forming ability
07/26/2000EP1021543A1 Mutants of yeast cdc24p, defective in binding of the g-protein beta subunit
07/26/2000EP1021539A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells
07/26/2000EP1021456A1 Macrocyclic 13-membered ring derivatives of erythromycins a and b
07/26/2000EP1021448A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS
07/26/2000EP1021444A1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES
07/26/2000EP1021442A1 8-azabicyclo 3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors
07/26/2000EP1021429A1 Aryl furan derivatives as pde iv inhibitors
07/26/2000EP1021425A1 N-aminoalkyl-2-anthraquinonecarboxamides; dopamine receptor subtype specific ligands
07/26/2000EP1021423A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF$g(a) SECRETION
07/26/2000EP1021415A1 Tricyclic aminoalkylcarboxamides; novel dopamine d 3? receptor subtype specific ligands
07/26/2000EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/26/2000EP1021410A1 Prostaglandin agonists and their use to treat bone disorders
07/26/2000EP1021407A1 Synthesis of clasto-lactacystin beta-lactone and analogs thereof
07/26/2000EP1021406A1 Novel anandamide amidase inhibitors as analgesic agents
07/26/2000EP1021402A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
07/26/2000EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive
07/26/2000EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS
07/26/2000EP1021196A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
07/26/2000EP1021195A1 Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine
07/26/2000EP1021190A1 Novel amide derivatives
07/26/2000EP1021182A1 Indeno[1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activity
07/26/2000EP1021181A1 Carboxylic acid indole inhibitors of chemokines
07/26/2000EP1021174A2 Medicaments
07/26/2000EP1021173A1 Use of csaid?tm compounds for the management of uterine contractions
07/26/2000EP1021172A1 Dosage form for aerosol administration
07/26/2000EP1021167A1 High and low load formulations of igf-i in multivesicular liposomes
07/26/2000EP0769054B1 Immunomodulators
07/26/2000EP0650374B1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant
07/26/2000EP0639976B1 Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient
07/26/2000CN1261373A Compositions and methods for activating genes of interest
07/26/2000CN1261367A Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
07/26/2000CN1261366A Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
07/26/2000CN1261365A Crystalline macrolides and process for their preparation
07/26/2000CN1261361A 5-(2-Ethyl-2H-tetrazol-5-Y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate
07/26/2000CN1261358A Angiogenesis inhiting 5-substituted-1,2,4-thiadiazolyl derivatives
1 ... 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 ... 1564